PATENT CLAIM ANALYSIS

Application Number: 16001697
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising a drug such as a triptan (e.g. rizatriptan) and/or an NSAID (e.g. meloxicam) in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the drug for the treatment of conditions such as pain.

Claim (Index 11):
The method of  claim 1 , wherein the dosage form contains about 400 mg to about 600 mg of the bicarbonate.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.52273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15976800', '15936176', '15986215', '16000701', '15984055']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8217997473064941
- 35 USC 102 Novelty (BERT): 0.5919433948595741
- Combined Prediction Score: 0.7988141120618021
- Mean Citation Score: 422.436214
- Max Citation Score: 479.27145
- Similarity Product: 417.6323988005519

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test